{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:22:41Z","timestamp":1791217361233,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.cmet.2015.08.002","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T11:48:01Z","timestamp":1441108081000},"page":"399-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":215,"title":["Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition"],"prefix":"10.1016","volume":"22","author":[{"given":"Tom\u00a0J.J.","family":"Schirris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.\u00a0Herma","family":"Renkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Ritschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00a0C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Bilos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel\u00a0G.M.","family":"van\u00a0Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner\u00a0J.H.","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien\u00a0D.","family":"Beyrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard\u00a0J.","family":"Rodenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter\u00a0H.G.M.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan\u00a0A.M.","family":"Smeitink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans\u00a0G.M.","family":"Russel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2015.08.002_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740338.2011.540568","article-title":"Statin-induced myopathy: a review and update","volume":"10","author":"Abd","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.cmet.2015.08.002_bib2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/clpt.2014.121","article-title":"Phenotype standardization for statin-induced myotoxicity","volume":"96","author":"Alfirevic","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmet.2015.08.002_bib3","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1111\/j.1538-7836.2004.01048.x","article-title":"Improvement of statin-associated myotoxicity by L-carnitine","volume":"2","author":"Arduini","year":"2004","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.cmet.2015.08.002_bib4","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2015.08.002_bib5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cmet.2013.11.012","article-title":"Does reduced creatine synthesis protect against statin myopathy?","volume":"18","author":"Ballard","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2015.08.002_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cmet.2015.08.002_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/10409239409086800","article-title":"The protonmotive Q cycle in mitochondria and bacteria","volume":"29","author":"Brandt","year":"1994","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.cmet.2015.08.002_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1432-1033.1988.tb14026.x","article-title":"Characterisation of binding of the methoxyacrylate inhibitors to mitochondrial cytochrome c reductase","volume":"173","author":"Brandt","year":"1988","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cmet.2015.08.002_bib9","doi-asserted-by":"crossref","first-page":"10345","DOI":"10.1016\/j.bmc.2008.10.030","article-title":"The role of molecular modeling in the design of analogues of the fungicidal natural products crocacins A and D","volume":"16","author":"Crowley","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cmet.2015.08.002_bib10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1586\/erc.12.92","article-title":"CoQ10 and L-carnitine for statin myalgia?","volume":"10","author":"DiNicolantonio","year":"2012","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.cmet.2015.08.002_bib11","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature13629","article-title":"GATM locus does not replicate in rhabdomyolysis study","volume":"513","author":"Floyd","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2015.08.002_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/CVM-2-5-205","article-title":"Withdrawal of cerivastatin from the world market","volume":"2","author":"Furberg","year":"2001","journal-title":"Curr. Control. Trials Cardiovasc. Med."},{"key":"10.1016\/j.cmet.2015.08.002_bib13","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.biocel.2009.03.013","article-title":"Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology","volume":"41","author":"Gnaiger","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cmet.2015.08.002_bib14","first-page":"3940","article-title":"The muscle-specific ubiquitin ligase atrogin-1\/MAFbx mediates statin-induced muscle toxicity","volume":"117","author":"Hanai","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2015.08.002_bib15","doi-asserted-by":"crossref","first-page":"e42866","DOI":"10.1371\/journal.pone.0042866","article-title":"A survey of the FDA\u2019s AERS database regarding muscle and tendon adverse events linked to the statin drug class","volume":"7","author":"Hoffman","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cmet.2015.08.002_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/tx400409c","article-title":"Drug-induced rhabdomyolysis: from systems pharmacology analysis to biochemical flux","volume":"27","author":"Hur","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cmet.2015.08.002_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1373\/clinchem.2005.062414","article-title":"Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology","volume":"52","author":"Janssen","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cmet.2015.08.002_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1373\/clinchem.2006.078873","article-title":"Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts","volume":"53","author":"Janssen","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cmet.2015.08.002_bib19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nprot.2008.61","article-title":"Analysis of mitochondrial function in\u00a0situ in permeabilized muscle fibers, tissues and cells","volume":"3","author":"Kuznetsov","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cmet.2015.08.002_bib20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy--a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cmet.2015.08.002_bib21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.cmet.2015.03.003","article-title":"GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals","volume":"21","author":"Luzum","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2015.08.002_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature12508","article-title":"A statin-dependent QTL for GATM expression is associated with statin-induced myopathy","volume":"502","author":"Mangravite","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2015.08.002_bib23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.cmet.2015.08.002_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-510X(97)05379-3","article-title":"Clinical heterogeneity in respiratory chain complex III deficiency in childhood","volume":"149","author":"Mourmans","year":"1997","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.cmet.2015.08.002_bib25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bcp.2009.12.007","article-title":"Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy","volume":"79","author":"Mullen","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cmet.2015.08.002_bib26","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.bbamcr.2011.07.019","article-title":"Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt","volume":"1813","author":"Mullen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cmet.2015.08.002_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nmd.2013.09.011","article-title":"Statin myotoxicity: a review of genetic susceptibility factors","volume":"24","author":"Needham","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.cmet.2015.08.002_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cmet.2015.08.002_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/dmd.30.5.505","article-title":"Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization","volume":"30","author":"Prueksaritanont","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cmet.2015.08.002_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ejhg.2014.80","article-title":"SDHA mutations causing a multisystem mitochondrial disease: novel mutations and genetic overlap with hereditary tumors","volume":"23","author":"Renkema","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cmet.2015.08.002_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10545-010-9081-y","article-title":"Biochemical diagnosis of mitochondrial disorders","volume":"34","author":"Rodenburg","year":"2011","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.cmet.2015.08.002_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coph.2007.12.010","article-title":"New insights into mechanisms of statin-associated myotoxicity","volume":"8","author":"Sirvent","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cmet.2015.08.002_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.taap.2012.01.008","article-title":"Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins","volume":"259","author":"Sirvent","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cmet.2015.08.002_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejps.2007.12.009","article-title":"Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in\u00a0vitro","volume":"33","author":"Skottheim","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.cmet.2015.08.002_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40291-013-0031-x","article-title":"UGT1A1\u221728 is associated with decreased systemic exposure of atorvastatin lactone","volume":"17","author":"Stormo","year":"2013","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.cmet.2015.08.002_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.trsl.2014.01.013","article-title":"Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies","volume":"164","author":"Taha","year":"2014","journal-title":"Transl. Res."},{"key":"10.1016\/j.cmet.2015.08.002_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cmet.2015.08.002_bib38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/0091270002042009002","article-title":"A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin","volume":"42","author":"White","year":"2002","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.cmet.2015.08.002_bib39","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1021\/ci3000776","article-title":"Pharmacophore fingerprint-based approach to binding site subpocket similarity and its application to bioisostere replacement","volume":"52","author":"Wood","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.cmet.2015.08.002_bib40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ajhg.2008.09.002","article-title":"Mutations in\u00a0LPIN1 cause recurrent acute myoglobinuria in childhood","volume":"83","author":"Zeharia","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cmet.2015.08.002_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmet.2014.05.003","article-title":"Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle","volume":"20","author":"Zhang","year":"2014","journal-title":"Cell Metab."}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413115003939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413115003939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T16:29:51Z","timestamp":1537374591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413115003939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1550413115003939"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2015.08.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725764716.793545760","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.725764716.793509822","asserted-by":"object"}]},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2015.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}